Pan-European Survey on the Under Treatment of Hypercholesterolemia

Completed

• Conditions: Hypercholesterolemia

• Registration Number: NCT00542867
• Lead Sponsor: AstraZeneca

Brief Summary

The survey try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Third Joint European Task Force guidelines, overall and by country.·

Detailed Description

Not available

Study Timeline

• Study Start: 2006-01
• Study First Submitted: 2007-10-11
• Study First Submitted QC: 2007-10-11
• Study First Posted: 2007-10-12
• Status Verified: 2007-11
• Study Completion: 2007-11
• Last Update Submitted: 2007-11-19
• Last Update Posted: 2007-11-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 6500

Inclusion Criteria

• Patients had to be on a lipid-lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The number and percentage of patients achieving the LDL-C goals, according to the Third Joint European Task Force guidelines, overall and by country.